Nuper, Shenzhen JMYMED Technology Co., Ltd. (Hereñafter Referred to as "JMED") habet feliciter complebitur medicamento Magister File (DMF et Drug / FDA products cum US Cibum et Drix Administration Portfolio), Praeterea expanding eius productum Portfolio.

De jymmed

Jymed est summus tech Biopharmaceutical turba specialiter in independens investigationis, progressionem, productio et sales de peptide-fundatur products, tum quod contractus progressionem et vestibulum organization (CDMO) officia. In comitatu est committitur providente summus qualis peptide apis et customized solutions ad global clients. Eius uber Portfolio includit dozens of peptide apis, cum core products ut semaglutide et Terlipressin habens iam complevit US FDA DMF limatura.

Et subsidiary, Hubei Jxbio pharmaceutical Co., Ltd., Operatur Status-of-De-arte peptide API productio lineas, qui propinquos meos cum CGMP signa constituit a US FDA, Europae EMA et Sinis scriptor NMPA Europae. Et facilitas includit X magna-scale et gubernator productio lineae et statutum est rigorous pharmaceutical qualis administratione ratio (qms) et environmental salutem et salus (EHS) administratione ratio. His totam processum a R & D ad productionem, occurrit summum internationalis signa. In comitatu est feliciter Transierunt GMP obsequio inspectiones ab utroque US FDA et Sinis scriptor NMPA et est agnita a ducens global pharmaceutical turmas ad EHs procuratio excellentiam, et environmental officio.

Core Business Areas:Domestic and international peptide API registration and compliance,Veterinary and cosmetic peptides,Custom peptide services, including CRO, CMO, and OEM solutions,Peptide-drug conjugates (PDCs), including peptide-radionuclide, peptide-small molecule, peptide-protein, and peptide-RNA therapeutics.

Products

Nam magis details nostris products, placere contactus nobis.

Global API et COLOR Inquisitores: Tel non.: + 86-15013529272;

API Registration & CDmo Services (USA EU Market): 86-15818682250

E-mail:jymed@jymedtech.com

Oratio: Triticum VIII & IX, I, Shenzhen Biomedical Innovation Industrial Park, XIV Jinhui Road, Kengzi subdristic, Pingshan regio, Shenzhen